PSCA Antikörper
-
- Target Alle PSCA Antikörper anzeigen
- PSCA (Prostate Stem Cell Antigen (PSCA))
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PSCA Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Antigen affinity purification
- Immunogen
- Synthetic peptide of human PSCA
- Isotyp
- IgG
- Top Product
- Discover our top product PSCA Primärantikörper
-
-
- Applikationshinweise
- WB 1:500-1:2000, IHC 1:20-1:100, ELISA 1:5000-1:10000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.78 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- PSCA (Prostate Stem Cell Antigen (PSCA))
- Andere Bezeichnung
- PSCA (PSCA Produkte)
- Synonyme
- PRO232 antikoerper, 2210408B04Rik antikoerper, PSCA antikoerper, prostate stem cell antigen antikoerper, PSCA antikoerper, Psca antikoerper, LOC482068 antikoerper
- Hintergrund
- PSCA (Prostate Stem Cell antigen) is a cell surface antigen, which is overexpressed in ~40 % of primary prostate cancers and in as many as 100 % of metastatic ones. PSCA is also overexpressed in a majority of transitional cell and pancreatic carcinomas. Antibody directed against PSCA inhibits tumorigenesis, slows tumor growth, prolongs survival and prevents metastasis in a preclinical zenograft model indicating that PSCA may have utility as a prognostic marker and/or therapeutic target in prostate cancer.
- Molekulargewicht
-
Observed_MW: Refer to figures
Calculated_MW: 13 kDa
- UniProt
- O43653
-